溶栓药物对取栓不完全再灌注后延迟再灌注的影响:目标试验模拟
本研究基于3项随机对照试验和2个卒中中心数据,采用目标试验模拟分析静脉溶栓对取栓不完全再灌注(eTICI 2a-2c)患者延迟再灌注的影响。832例患者中511例(61%)出现延迟再灌注,静脉溶栓对延迟再灌注有独立治疗效应(sRR 1.1,95%CI 1.0-1.3;sRD 8.2%,95%CI 0.2%-16.1%)。在接受溶栓的患者中,溶栓给药至干预结束时间每增加1小时,延迟再灌注风险降低(sRR 0.93%,95%CI 0.87-0.98;sRD -5.2%,95%CI -9.1%至-1.3%)。
要点
- 取栓后不完全再灌注(eTICI 2a-2c)患者中61%出现延迟再灌注。
- 静脉溶栓对延迟再灌注有独立治疗效应(sRR 1.1,95%CI 1.0-1.3)。
- 溶栓至干预结束时间每增加1小时,延迟再灌注风险降低(sRR 0.93%)。
核心结论
- 在取栓不完全再灌注且24小时灌注成像的患者中,溶栓暴露对延迟再灌注的发生显示独立治疗效应。
- 当近端血管再通时溶栓药物可能达到治疗浓度而远端闭塞持续和/或发生时,观察到溶栓对延迟再灌注的效应。
研究设计与样本
- 汇总3项随机对照试验(EXTEND-IA和EXTEND-IA TNK第1、2部分)和2个综合卒中中心(Graz和Bern大学医院)的数据进行分析。
- 仅纳入最终再灌注评分为eTICI 2a-2c且随访24±12小时有可用灌注成像的患者。
- 采用目标试验模拟以处理观察性数据中的混杂。
主要发现
- 832例eTICI 2a-2c患者(中位年龄74岁,49%女性)中,511例(61%)出现延迟再灌注。
- 调整年龄、性别、心房颤动、 device passes数、侧支评分和eTICI后,静脉溶栓对延迟再灌注有独立治疗效应(sRR 1.1,95%CI 1.0-1.3;sRD 8.2%,95%CI 0.2%-16.1%)。
- 在接受溶栓的患者(n=524/832,63%)中,调整上述协变量后,溶栓给药至干预结束时间每增加1小时,延迟再灌注风险降低(sRR 0.93%,95%CI 0.87-0.98;sRD -5.2%,95%CI -9.1%至-1.3%)。
局限性
- 本研究为非随机化研究,治疗组基线特征存在显著差异,证据等级为Class III。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: More than half of the endovascularly treated ischemic stroke patients with incomplete reperfusion (expanded Thrombolysis in Cerebral Infarction [eTICI] <3) show delayed reperfusion (DR) on 24-hour perfusion imaging, which is associated with favorable clinical outcome. The effect of intravenous thrombolysis (IVT) on the rates of DR remains unclear. This study aimed to assess the treatment effect of IVT on the occurrence of DR. METHODS: Pooled data from 3 randomized controlled trials (EXTEND-IA and EXTEND-IA TNK parts 1 and 2) and 2 comprehensive stroke centers (University Hospitals Graz and Bern) were analyzed. Only patients with a final reperfusion score of eTICI 2a-2c and available perfusion imaging at follow-up of 24 ± 12 hours were included. The primary outcome was the presence of DR on 24-hour follow-up CT/MRI perfusion imaging, defined as the absence of any focal perfusion deficit on perfusion imaging, despite incomplete reperfusion on the final angiography series during thrombectomy. For the secondary analysis, we explored the association between the primary outcome (DR) and the time elapsed between start of IVT and the end of an intervention. To address confounding in observational data, we performed a target trial emulation. RESULTS: Of 832 included patients with eTICI 2a-2c (median age 74 years, 49% female), 511 (61%) had DR. There was an independent treatment effect of IVT on DR (standardized risk ratio [sRR] 1.1, 95% CI 1.0-1.3; standardized risk difference [sRD] 8.2%, 95% CI 0.2%-16.1%), after adjusting for age, sex, atrial fibrillation, number of device passes, collateral score, and eTICI. Among those patients who have received IVT (n = 524/832, 63%), when adjusting for the aforementioned covariates, there was a causal effect of shorter time between administration of thrombolytics and end of the intervention on DR (sRR 0.93%, 95% CI 0.87-0.98; sRD -5.2%; 95% CI -9.1% to -1.3%, per hour increase). DISCUSSION: Exposure to thrombolytics showed independent treatment effect on the occurrence of DR among patients with incomplete reperfusion after thrombectomy who undergo perfusion imaging at the 24-hour follow-up. The effect of thrombolytics on DR was observed if there was a high chance of therapeutic concentrations of thrombolytics at the time point when the proximal vessel was recanalized, but distal occlusions persisted and/or occurred. CLASSIFICATION OF EVIDENCE: This study is rated Class III because it is a nonrandomized study and there are substantial differences in baseline characteristics of the treatment groups.
引用
- Mujanovic A, Yogendrakumar V, Ng FC, et al. Effect of Thrombolytics on Delayed Reperfusion After Incomplete Thrombectomy: Target Trial Emulation. Neurology. 2025. PMID: 40294370. doi:10.1212/WNL.0000000000213641
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。